skip to content

Cambridge Immunology Network



Key publications: 

Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostör AJ, Hall FC, Rudd JH, Wilkinson IB. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation. 2012 Nov 20;126(21):2473-80.

Malaviya AP, Hall FC. Targeting CVD risk in chronic connective tissue disease. Practitioner. 2012 Jan;256(1747):21-6, 3.

Busch R, Hadjinicolaou AV, Hall FC. Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndrome. Curr Pharm Biotechnol. 2012 Aug;13(10):2009-21.

Fang B, Bhagat S, Busch R, Parfrey H, Hall FC. Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab. Rheumatology (Oxford). 2011 May;50(5):992-4.

Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007 Aug 28;50(9):852-8.

Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology (Oxford). 2005 Dec;44(12):1473-82.

Dr Frances  Hall
Takes PhD students
Not available for consultancy